A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, Elderly Hospitalized Patients With Influenza A Infection
|Effective start/end date||10/1/18 → 10/30/21|
- JANSSEN RESEARCH & DEVELOPMENT, LLC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.